Tianjin, China

Yibing Cheng

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 8.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Yibing Cheng: Innovator in Transaminase and Monooxygenase Mutants

Introduction

Yibing Cheng, located in Tianjin, China, is an accomplished inventor with a focus on biocatalysis and enzyme engineering. He holds a total of five patents, showcasing his innovative contributions to the field. His work primarily involves the development of transaminase and monooxygenase mutants, which have significant industrial applications.

Latest Patents

Yibing Cheng's latest patents include:

1. **Transaminase Mutant and Use Thereof**: This invention provides a transaminase mutant with specific amino acid sequence mutations that result in improved enzyme functionality. The mutations enhance the enantiomeric excess (ee) value of the product while reducing the enzyme amount necessary for reactions. This advancement streamlines post-processing and makes the mutant suitable for industrial production.

2. **Monooxygenase Mutant and Use Thereof**: This patent discloses a monooxygenase mutant derived from specific amino acid mutations. The unique mutations at designated sites lead to improved catalytic properties, offering potential for various biotechnological applications.

Career Highlights

Yibing Cheng has made significant contributions to several reputable companies throughout his career. Notably, he has worked at Asymchem Life Science (Tianjin) Co., Ltd and Jilin Asymchem Laboratories Co., Ltd. His experience in these organizations has been instrumental in advancing his research and innovation in enzyme technology.

Collaborations

Throughout his professional journey, Yibing Cheng has collaborated with esteemed colleagues, including Yulei Ma and Jiangping Lu. These collaborations have fostered a robust exchange of ideas and expertise, culminating in several key innovations in the field of biocatalysis.

Conclusion

Yibing Cheng stands out as a pioneering inventor in the realm of transaminase and monooxygenase mutants. His patents reflect a commitment to enhancing enzyme application in industrial settings. Through his collaborations and career trajectory, Cheng continues to influence the field of biocatalysis, driving innovation forward.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…